LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

3.86 -2.53

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.82

Max

4.05

Belangrijke statistieken
By Trading Economics
Inkomsten	1.6M -12M
Verkoop	554K 18M
EPS	-0.536
Winstmarge	-65.968
Werknemers	226
EBITDA	1.6M -9.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+58.65% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-2.5M 121M
Vorige openingsprijs	6.39
Vorige sluitingsprijs	3.86

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 mrt 2026, 23:43 UTC

Marktinformatie

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mrt 2026, 23:36 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mrt 2026, 23:35 UTC

Acquisities, Fusies, Overnames

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mrt 2026, 23:29 UTC

Winsten

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mrt 2026, 23:28 UTC

Winsten

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mrt 2026, 23:28 UTC

Winsten

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mrt 2026, 23:28 UTC

Winsten

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mrt 2026, 23:27 UTC

Winsten

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mrt 2026, 23:27 UTC

Winsten

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mrt 2026, 23:08 UTC

Marktinformatie

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mrt 2026, 23:04 UTC

Acquisities, Fusies, Overnames

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mrt 2026, 22:41 UTC

Acquisities, Fusies, Overnames

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mrt 2026, 22:41 UTC

Acquisities, Fusies, Overnames

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mrt 2026, 22:26 UTC

Winsten

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mrt 2026, 22:26 UTC

Winsten

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mrt 2026, 22:26 UTC

Winsten

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mrt 2026, 22:08 UTC

Winsten

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mrt 2026, 22:08 UTC

Winsten

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mrt 2026, 22:08 UTC

Winsten

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mrt 2026, 22:07 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Energy Roundup: Market Talk

26 mrt 2026, 22:07 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mrt 2026, 22:00 UTC

Winsten

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mrt 2026, 22:00 UTC

Winsten

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mrt 2026, 22:00 UTC

Winsten

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mrt 2026, 21:39 UTC

Acquisities, Fusies, Overnames

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mrt 2026, 21:38 UTC

Acquisities, Fusies, Overnames

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

58.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.33 USD 58.65%

Hoogste 10 USD

Laagste 3.5 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.